Related Experiment Video
Updated: May 14, 2025

06:06
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
2.3K
Is Postoperative Steroid Use Associated With Improved Outcomes in Severe Odontogenic Infections?
Brian J Christensen1, Earl Peter Park2
1Associate Professor, Oral and Maxillofacial Surgery, Geisinger Commonwealth School of Medicine, Geisinger Health System, Danville, PA.
Summary
Postoperative steroid use did not significantly impact length of stay or reoperation rates in severe odontogenic infections. This study found no benefit in using steroids for these patients.
Area of Science:
- Oral and Maxillofacial Surgery
- Infectious Diseases
- Pharmacology
Background:
- Steroids are commonly used for odontogenic infections, but evidence on their efficacy is limited.
- Few studies have investigated the impact of steroids on outcomes for these infections.
Purpose of the Study:
- To determine if postoperative steroid use affects length of stay (LOS) and reoperation in severe odontogenic infections.
- To analyze the association between steroid administration and patient recovery metrics.
Main Methods:
- A prospective cohort study included 240 adult patients with severe odontogenic infections.
- Data on postoperative steroid use, total LOS, postsurgical LOS, and reoperation were collected and analyzed.
- Descriptive, bivariate, and linear regression analyses were performed.
Main Results:
- Postoperative steroids were administered to 47.5% of patients.
- No significant association was found between steroid use and total LOS (P = .59).
- Steroid use did not significantly affect postsurgical LOS (P = .13) or reoperation rates (P = .56).
Conclusions:
- Postoperative steroid administration is not associated with reduced length of stay or reoperation in severe odontogenic infections.
- The findings suggest that steroids may not offer clinical benefits for improving outcomes in these conditions.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
89
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
89
Tonsillitis II: Management
96
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
96

